India: Healthcare and pharma scenario dismal
| The drug regulator, according to this post is not the only corrupt body in the visible landscape in this sector – many more such ministries and bodies are involved in callousness and corruption. Here’s an example – the Drug Controller General of India (DCGI) approved 31 new drugs between January 2008 and October 2010 despite mandatory clinical trials on patients in India not being conducted. Read more here.
|
Featured Blog Posts
Get The Latest From The Social Sector In Your Inbox!
Subscribe to our newsletter
